PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-62.13%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-65.00%
Negative gross profit growth while MAXN is at 73.39%. Joel Greenblatt would examine cost competitiveness or demand decline.
-108.93%
Negative EBIT growth while MAXN is at 71.83%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-106.87%
Negative operating income growth while MAXN is at 66.50%. Joel Greenblatt would press for urgent turnaround measures.
-107.11%
Negative net income growth while MAXN stands at 73.10%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-107.05%
Negative EPS growth while MAXN is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-108.75%
Negative diluted EPS growth while MAXN is at 73.09%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.49%
Share change of 0.49% while MAXN is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
-19.53%
Reduced diluted shares while MAXN is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-192.69%
Negative OCF growth while MAXN is at 93.92%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-481.43%
Negative FCF growth while MAXN is at 91.23%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
5.36%
Positive 10Y revenue/share CAGR while MAXN is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-8.51%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-24.46%
Negative 3Y CAGR while MAXN stands at 7.06%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
83.11%
Positive long-term OCF/share growth while MAXN is negative. John Neff would see a structural advantage in sustained cash generation.
-532.42%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
29.72%
Positive 3Y OCF/share CAGR while MAXN is negative. John Neff might see a big short-term edge in operational efficiency.
96.49%
Positive 10Y CAGR while MAXN is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-154.92%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
89.12%
Positive short-term CAGR while MAXN is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
-24.23%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
1.53%
Positive short-term equity growth while MAXN is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative near-term dividend growth while MAXN invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-11.26%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
45.07%
We show growth while MAXN is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-5.58%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-1.43%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-13.00%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-6.85%
Our R&D shrinks while MAXN invests at 3.39%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
3.64%
We expand SG&A while MAXN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.